IKT
#3412
Inhibikase Therapeutics, Inc. - Common Stock
2.2 2 USD
+0.13%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+13.27%
Variación mensual
+30.59%
Variación en los últimos 6 meses
+30.59%
Cambio anual
+14.43%
Cierres anteriores
1.9 6
Open
2.2 1
Mínimo
2.2 0
High
2.3 6
Volumen
1 312
Financials
- Market Capitalization 293.11 M
- Employee 35
- Founded 2008
- CEO N/A
- Website www.inhibikase.com
- Headquarter Delaware, United States
- FIGI BBG005TP2339
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.18
Relación precio/flujo de caja
53.93
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3387 |  TTRX Turn Therapeutics Inc. - Common Stock | 9.52 USD | +0.53% | +12.93% | +54.05% | -4.80% | 283.58 M USD | ||
| 3404 |  MGNX MacroGenics, Inc. - Common Stock | 4.37 USD | -2.89% | -6.62% | +10.35% | +178.34% | 277.77 M USD | ||
| 3416 |  GLSI Greenwich LifeSciences, Inc. - Common stock | 18.61 USD | +0.22% | -7.87% | -23.79% | +74.09% | 273.16 M USD | ||
| 3417 |  NAGE Niagen Bioscience, Inc. - Common Stock | 3.37 USD | -2.88% | -4.26% | -3.16% | -32.33% | 268.40 M USD |